The data displays the distribution of major causes for pharmaceutical product recalls in the United States as of Q4 2017. During this quarter, almost every third recall was due to failed specs.
Failed Specs | 30.4 |
Mislabeling | 17.4 |
No NDA/ ANDA | 11.6 |
cGMP deviations | 10.1 |
Foreign materials | 10.1 |